Telix Pharmaceuticals Limited
TLX | NASDAQ
$11.98
+$0.67 (+5.92%)
Sep 22, 2026, 2:02 PM ET · Market open
Market Data
Market Cap $3.83B
Enterprise Value $6.01B
Beta 0.60
Average Volume 153.87K
Shares Outstanding (Diluted) 356.89M
Shares Change YoY 1.75%
Institutional Ownership 0.76%
Exchange NASDAQ
ISIN US87961M1053
Price Performance
Price Change 1M -1.3%
Price Change 3M 10.8%
Price Change 6M 27.1%
Price Change YTD 48.4%
Price Change 1Y 12.5%
Price Change 3Y -23.8%
Price Change 5Y -23.8%
1M CAGR (ann.) -1.8%
1Y CAGR (ann.) 23.5%
5Y CAGR (ann.) N/A
All-Time CAGR -14.6%
Valuation
PE Ratio 119.12
Forward PE 796.71
PEG Ratio -0.43
Forward PEG -1.45
PS Ratio 4.31
Forward PS 3.30
PB Ratio 7.87
P/FCF Ratio -65.16
P/Adj. FCF Ratio -65.16
P/OCF Ratio -277.94
EV/Sales 4.58
EV/EBIT -677.41
EV/EBITDA 130.06
EV/FCF -69.33
Earnings Yield 0.9%
FCF Yield -1.6%
Adj. FCF Yield -1.6%
Financial Health
Net Debt A$387.42M
Total Debt A$837.03M
Cash & Short-Term Investments A$363.63M
Total Assets A$1.97B
Current Ratio 2.01
Quick Ratio 1.85
Debt / Equity Ratio 1.19
Debt / EBITDA 18.11
Debt / FCF -9.65
OCF / Debt -0.02
Interest Coverage -0.51
Altman Z-Score 3.39
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 52.2%
Operating Profit Margin -0.8%
EBITDA Margin 3.5%
Net Profit Margin 3.6%
FCF Margin -6.6%
Adj. FCF Margin -6.6%
SBC / Revenue 0.0%
SBC Impact (per share) N/A
Returns
Return on Assets 2.4%
Return on Equity 7.1%
Return on Invested Capital -0.6%
Return on Capital Employed -0.6%
Return on Tangible Assets 4.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 637.2%
Revenue CAGR 5Y 85.2%
Revenue CAGR 10Y 43.9%
EPS CAGR 3Y 486.8%
EPS CAGR 5Y 66.0%
EPS CAGR 10Y 4.6%
FCF CAGR 3Y 7.8%
FCF CAGR 5Y -24.1%
FCF CAGR 10Y -14.6%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 5
EPS Growth Next 3Y 54.9%
Revenue Growth Next 3Y 16.5%
Earnings Date Feb 18, 2027
EPS Estimate (next Q) -$0.02
EPS Growth Est (next Q) 83.2%
Revenue Est (next Q) $351.08M
Revenue Growth Est (next Q) 19.6%
Fair Value Estimates
Graham Number $1.77
Graham Upside -84.3%
Lynch Fair Value $2.37
Lynch Upside -79.0%
Price Target $18
Price Target Upside 59.2%
Cash Flow
Operating Cash Flow A$-19.19M
Free Cash Flow A$-86.7M
Adj. Free Cash Flow A$-86.7M
FCF Per Share -$0.26
OCF Per Share -$0.06
OCF/S Ratio -1.6%
Income Statement
Revenue A$1.31B
Gross Profit A$684.05M
Operating Income A$-10.09M
EBITDA A$46.22M
Net Income A$48.26M
EPS (Diluted) $0.14
Revenue / Employee $1.14M
Profit / Employee $41.89K
Employees 1,152
Add to Watchlist
Select watchlists to add or remove TLX